04.03.2014 Views

TDS pBLAST42-mcs - InvivoGen

TDS pBLAST42-mcs - InvivoGen

TDS pBLAST42-mcs - InvivoGen

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>pBLAST42</strong>-<strong>mcs</strong><br />

A plasmid containing the IL-2 signal sequence, a multiple cloning site and the blasticidin resistance gene<br />

Catalog # pbla42-<strong>mcs</strong><br />

For research use only<br />

Version # 05H11-MT<br />

P R O D U C T I N F O R M AT I O N<br />

C o n t e n t :<br />

- 20 µg of lyophilized <strong>pBLAST42</strong>-<strong>mcs</strong> plasmid DNA.<br />

- 4 pouches of E. coli F a s t - M e d i a ® Blast (2 for agar media, 2 for liquid media).<br />

Storage and stability:<br />

- Products are shipped at room temperature.<br />

- Upon receipt, resuspend lyophilized DNA and store at -20°C. Avoid repeated<br />

freeze-thaw cycles.<br />

- Store E. coli F a s t - M e d i a ® Blas at room temperature. Fast-Media ® pouches are<br />

stable 18 months when stored properly.<br />

Quality contro l :<br />

- Plasmid DNA was prepared using an affinity column and lyophilized.<br />

- Plasmid construct has been confirmed by restriction analysis sequencing.<br />

G E N E R A L P R O D U C T U S E<br />

<strong>pBLAST42</strong>-<strong>mcs</strong> is a ready-made expression vector containing the Blasticidin<br />

resistance gene, the hybrid EF1α/ H T LV promoter and a multiple cloning site.<br />

p B L A S T 4 2 - m c s may be used for:<br />

Cloning in a gene of intere s t. Four unique restriction sites comprise the MCS<br />

facilitating cloning of genes. Cloned genes will be under the control of the<br />

E F 1α/ H T LV p r o m o t e r. Genes lacking a native signal sequence will be secreted<br />

as the MCS is located downstream of the human IL-2 signal sequence.<br />

As an “empty” control vector. Since <strong>pBLAST42</strong>-<strong>mcs</strong> does not contain a<br />

therapeutic gene, it can be used in conjunction with other vectors of the pBLAST<br />

family to serve as an experimental control.<br />

p B L A S T is selectable with blasticidin in both E. coli and mammalian cells.<br />

PLASMID FEAT U R E S<br />

• EF-1α / HTLV hybrid pro m o t e r i s a composite promoter comprised of the<br />

Elongation Factor- 1α( E F - 1α) promoter 1 and 5’untranslated region of the Human<br />

T-Cell Leukemia Virus (HTLV). EF-1α is a ‘housekeeping’ gene ubiquitously<br />

expressed in eukaryotic cells. The EF-1α promoter exhibits a strong activity,<br />

higher than viral promoters and, on the contrary to the CMV p r o m o t e r, yields<br />

persistent expression of the transgene in vivo. The R segment and part of the U5<br />

sequence (R-U5’) of the HTLV Type 1 Long Terminal Repeat 2 has been coupled<br />

to the EF-1α promoter to enhance stability of DNA and RNA. This modification<br />

not only increases steady state transcription, but also significantly increases<br />

translation efficiency possibly through mRNA s t a b i l i z a t i o n .<br />

• I117 is a bacterial promoter that is spliced out as an intron in mammalian cells.<br />

Expression of the transgene in E. coli can be further increased by the addition of<br />

IPTG when working with bacteria that constitutively express L a c I<br />

• SV40 polyA: The Simian Virus 40 late polyadenylation signal enables eff i c i e n t<br />

cleavage and polyadenylation reactions resulting in high levels of steady-state<br />

mRNA. The efficiency of this signal was first described by Carswell et al. 3<br />

• SpAn: A synthetic polyadenylation site and a strong pause site are placed<br />

downstream of the pMB1 Ori to limit transcriptional interference between both<br />

transcriptional units. The synthetic polyA site is based on the highly eff i c i e n t<br />

p o l y A signal of the rabbit β-globin gene 4 .<br />

• IL2 ss: The IL2 signal sequence contains 21 amino acids and share common<br />

characteristics with signal peptides of other secretory proteins with respect to<br />

abundance and positions of hydrophobic amino acids. The intracellular cleavage<br />

of the IL2 signal peptide occurs after Ser20 and leads to the secretion of the<br />

expressed protein.<br />

Note: The gene of interest must be cloned in frame with the IL-2ss as translation<br />

will begin at the ATG of the IL-2ss.<br />

• Multiple cloning site.<br />

The MCS contains the restriction sites N r u I, A s c I, B s sH II a n d N h e I.<br />

N ru I is compatible with any blunt-end restriction enzyme.<br />

A s c I is compatible with A f l III, M l u I and B s sH II<br />

B s sH II is compatible with A s c I, A f l III and M l u I .<br />

N h e I is compatible with Xba I, Spe I, and Av r I I .<br />

• pMB1 Ori is a minimal E. coli origin of replication with the same activity as<br />

the longer Ori.<br />

• SV40 prom: The Simian Virus 40 promoter allows the expression of the<br />

blasticidin resistance gene in mammalian cells.<br />

• Bsr (blasticidin resistance gene): The b s r gene from Bacillus cereus e n c o d e s<br />

a deaminase that confers resistance to the antibiotic Blasticidin S. The b s r gene is<br />

driven by the SV40 promoter in tandem with the bacterial EM7 promoter.<br />

Therefore each pBLAST plasmid can be used to select stable mammalian cells<br />

transfectants and E. coli t r a n s f o r m a n t s .<br />

• bGh pAn: The bovine growth hormone (bGh) polyadenylation (pAn) signal<br />

and a transcriptional pause are placed 3' of the blasticidin gene. The bGh pAn has<br />

been shown to be as efficient as SV40 and HSV1tk polyadenylation signals in<br />

many different cell types 5 . The use of bGH pAn minimizes interference and<br />

possible recombination events with the SV40 polyadenylation signal. The pause<br />

site prevents transcriptional interference and read-through.<br />

R e f e re n c e s<br />

1- Kim et al (1990). Gene 2: 217-223.<br />

2- Takebe et al (1988). Mol. Cell Biol. 1: 466-472.<br />

3- Carswell et al(1989). Mol. Cell Biol. 10: 4248-4258.<br />

4- Levitt et al. (1989). Genes Dev. 7: 1019-1025.<br />

5- Goodwin et al. (1992). J. Biol. Chem. 23: 16330-16334.<br />

M E T H O D S<br />

Plasmid re s u s p e n s i o n :<br />

Quickly spin the tube containing the lyophilized plasmid to pellet the DNA. To<br />

obtain a plasmid solution at 1µg/µl, resuspend the DNA in 20µl of sterile H 2 O .<br />

Store resuspended plasmid at -20°C.<br />

Selection of bacteria with E. coli Fast-Media Blas:<br />

E. coli F a s t - M e d i a ® Blas is a n e w, fast and convenient way to prepare liquid and<br />

solid media for bacterial culture by using only a microwave. E. coli F a s t - M e d i a ®<br />

Blas is a TB (liquid) or LB (solid) based medium with blasticidin, and contains<br />

stabilizers. E. coli F a s t - M e d i a ® Blas can be ordered separately (catalog code # fasbl-l,<br />

fas-bl-s).<br />

M e t h o d :<br />

1- Pour the contents of a pouch into a clean borosilicate glass bottle or flask.<br />

2- Add 200 ml of distilled water to the flask<br />

3- Heat in a microwave on MEDIUM power setting (about 400Watts), until<br />

bubbles start appearing (approximately 3 minutes). Do not heat a closed<br />

c o n t a i n e r. Do not autoclave Fast-Media ® .<br />

4- Swirl gently to mix the preparation. Be careful, the bottle and media are hot,<br />

use heatproof pads or gloves and care when handling.<br />

5- Reheat the media for 30 seconds and gently swirl again. Repeat as necessary<br />

to completely dissolve the powder into solution. But be careful to avoid<br />

overboiling and volume loss.<br />

6- Let agar medium cool to 45˚C before pouring plates. Let liquid media cool to<br />

37˚C before seeding bacteria.<br />

N o t e : Do not reheat solidified Fast-Media ® as the antibiotic will be permanently<br />

d e s t royed by the pro c e d u re .<br />

TECHNICAL SUPPORT<br />

Toll free (US): 888-457-5873<br />

Outside US: (+1) 858-457-5873<br />

E-mail: info@invivogen.com<br />

Website: www.invivogen.com<br />

3950 Sorrento Valley Blvd. Suite A<br />

San Diego, CA 92121 - USA


NotI (2952)<br />

XhoI (2947)<br />

SgfI (7)<br />

AgeI (90)<br />

PvuII (240)<br />

HindIII (246)<br />

EcoRI (2666)<br />

hEF1/HTLV prom<br />

EcoRV (551)<br />

SalI (630)<br />

BspHI (2237)<br />

Bsr<br />

EM7<br />

<strong>pBLAST42</strong>-<strong>mcs</strong><br />

(3116 bp)<br />

I117<br />

hIL2ss<br />

PvuII (659)<br />

SgrAI (669)<br />

EcoRI (743)<br />

NruI (747)<br />

AscI (753)<br />

BssHII (754)<br />

NheI (761)<br />

AseI (2180)<br />

HpaI (924)<br />

AvrII (2110)<br />

SV40 prom<br />

SwaI (1022)<br />

NcoI (2017)<br />

pMB1 Ori<br />

100


1<br />

101<br />

201<br />

301<br />

401<br />

501<br />

601<br />

701<br />

4<br />

801<br />

901<br />

1001<br />

1101<br />

1201<br />

1301<br />

1401<br />

1501<br />

1601<br />

1701<br />

1801<br />

1901<br />

2001<br />

2101<br />

SgfI (7) AgeI (90)<br />

GGATCTGCGATCGCTCCGGTGCCCGTCAGTGGGCAGAGCGCACATCGCCCACAGTCCCCGAGAAGTTGGGGGGAGGGGTCGGCAATTGAACCGGTGCCTA<br />

GAGAAGGTGGCGCGGGGTAAACTGGGAAAGTGATGTCGTGTACTGGCTCCGCCTTTTTCCCGAGGGTGGGGGAGAACCGTATATAAGTGCAGTAGTCGCC<br />

HindIII (246)<br />

PvuII (240)<br />

GTGAACGTTCTTTTTCGCAACGGGTTTGCCGCCAGAACACAGCTGAAGCTTCGAGGGGCTCGCATCTCTCCTTCACGCGCCCGCCGCCCTACCTGAGGCC<br />

GCCATCCACGCCGGTTGAGTCGCGTTCTGCCGCCTCCCGCCTGTGGTGCCTCCTGAACTGCGTCCGCCGTCTAGGTAAGTTTAAAGCTCAGGTCGAGACC<br />

GGGCCTTTGTCCGGCGCTCCCTTGGAGCCTACCTAGACTCAGCCGGCTCTCCACGCTTTGCCTGACCCTGCTTGCTCAACTCTACGTCTTTGTTTCGTTT<br />

EcoRV (551)<br />

TCTGTTCTGCGCCGTTACAGATCCAAGCTGTGACCGGCGCCTACgtaagtgatatctactagatttatcaaaaagagtgttgacttgtgagcgctcacaa<br />

SalI (630) PvuII (659) SgrAI (669)<br />

ttgatacttagattcatcgagagggacacgtcgactactaaccttcttctctttcctacagCTGAGATCACCGGCGAAGGAGGGCCACCATGTACAGGAT<br />

1 MetTyrArgMe<br />

BssHII (754)<br />

AscI (753)<br />

NruI (747)<br />

EcoRI (743)<br />

NheI (761)<br />

GCAACTCCTGTCTTGCATTGCACTAAGTCTTGCACTTGTCACGAATTCGCGAGGCGCGCCGCTAGCTCGACATGATAAGATACATTGATGAGTTTGGACA<br />

tGlnLeuLeuSerCysI leAlaLeuSerLeuAlaLeuValThrAsnSer<br />

AACCACAACTAGAATGCAGTGAAAAAAATGCTTTATTTGTGAAATTTGTGATGCTATTGCTTTATTTGTGAAATTTGTGATGCTATTGCTTTATTTGTAA<br />

HpaI (924)<br />

CCATTATAAGCTGCAATAAACAAGTTAACAACAACAATTGCATTCATTTTATGTTTCAGGTTCAGGGGGAGGTGTGGGAGGTTTTTTAAAGCAAGTAAAA<br />

SwaI (1022)<br />

CCTCTACAAATGTGGTAGATCATTTAAATGTTAATTAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGT<br />

TTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCC<br />

CCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCAATGC<br />

TCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTA<br />

ACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTAC<br />

AGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGT<br />

AGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTT<br />

TGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGGCTAGTTAATTAAGCTGTACACTGTGGAATGTGTG<br />

TCAGTTAGGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCAGGTGTGGAAAGTCCCCAGGC<br />

TCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCATAGTCCCGCCCCTAACTCCGCCCATCCCGCCCCTAACTCCGCCCAGTT<br />

NcoI (2017)<br />

CCGCCCATTCTCCGCCCCATGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGCCGCCTCTGCCTCTGAGCTATTCCAGAAGTAGTGAGGAGGCTT<br />

AvrII (2110) AseI (2180)<br />

TTTTGGAGGCCTAGGCTTTTGCAAAAAGCTCCCGGGAGCTTGTATATCCATTTTCGGATCTGATcagCACGTGTTGACAATTAATCATCGGCATAGTATA<br />

BspHI (2237)<br />

2201 TCGGCATAGTATAATACGACAAGGTGAGGAACTAAATCATGAAGACCTTCAACATCTCTCAGCAGGATCTGGAGCTGGTGGAGGTCGCCACTGAGAAGAT<br />

1 MetLysThrPheAsnI leSerGlnGlnAspLeuGluLeuValGluValAlaThrGluLysI l<br />

2301 CACCATGCTCTATGAGGACAACAAGCACCATGTCGGGGCGGCCATCAGGACCAAGACTGGGGAGATCATCTCTGCTGTCCACATTGAGGCCTACATTGGC<br />

21 eThrMetLeuTyrGluAspAsnLysHisHisValGlyAlaAlaI leArgThrLysThrGlyGluI leI leSerAlaValHisI leGluAlaTyrI leGly<br />

2401 AGGGTCACTGTCTGTGCTGAAGCCATTGCCATTGGGTCTGCTGTGAGCAACGGGCAGAAGGACTTTGACACCATTGTGGCTGTCAGGCACCCCTACTCTG<br />

55 ArgValThrValCysAlaGluAlaI leAlaI leGlySerAlaValSerAsnGlyGlnLysAspPheAspThrI leValAlaValArgHisProTyrSerA<br />

2501 ATGAGGTGGACAGATCCATCAGGGTGGTCAGCCCCTGTGGCATGTGCAGAGAGCTCATCTCTGACTATGCTCCTGACTGCTTTGTGCTCATTGAGATGAA<br />

88 spGluValAspArgSerI leArgValValSerProCysGlyMetCysArgGluLeuI leSerAspTyrAlaProAspCysPheValLeuI leGluMetAs<br />

EcoRI (2666)<br />

2601 TGGCAAGCTGGTCAAAACCACCATTGAGGAACTCATCCCCCTCAAGTACACCAGGAACTAAACCTGAATTCGCTAGAGGGCCCTATTCTATAGTGTCACC<br />

121 nGlyLysLeuValLysThrThrI leGluGluLeuI leProLeuLysTyrThrArgAsn•••<br />

2701 TAAATGCTAGAGCTCGCTGATCAGCCTCGACTGTGCCTTCTAGTTGCCAGCCATCTGTTGTTTGCCCCTCCCCCGTGCCTTCCTTGACCCTGGAAGGTGC<br />

2801 CACTCCCACTGTCCTTTCCTAATAAAATGAGGAAATTGCATCGCATTGTCTGAGTAGGTGTCATTCTATTCTGGGGGGTGGGGTGGGGCAGGACAGCAAG<br />

NotI (2952)<br />

XhoI (2947)<br />

2901 GGGGAGGATTGGGAAGACAATAGCAGGCATGCGCAGGGCCCAATTGCTCGAGCGGCCGCAATAAAATATCTTTATTTTCATTACATCTGTGTGTTGGTTT<br />

3001 TTTGTGTGAATCGTAACTAACATACGCTCTCCATCAAAACAAAACGAAACAAAACAAACTAGCAAAATAGGCTGTCCCCAGTGCAAGTGCAGGTGCCAGA<br />

3101 ACATTTCTCTATCGAA

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!